AgeX Therapeutics Overview

  • Founded
  • 2017
  • Status
  • Public
  • Employees
  • 11
  • Stock Symbol
  • AGE
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.90
  • (As of Friday Closing)

AgeX Therapeutics General Information


AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 1010 Atlantic Avenue
  • Suite 102
  • Alameda, CA 94501
  • United States
+1 (510) 000-0000

AgeX Therapeutics Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AgeX Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.90 $0.90 $0.90 - $3.06 $34.3M 37.9M 69.6K -$0.26

AgeX Therapeutics Financials Summary

In Thousands,
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 65,303 61,608 66,107 107,042
Revenue 1,032 1,868 1,728 1,396
EBITDA 361,236 (8,945) (11,314) (7,312)
Net Income (9,551) (10,865) (12,154) (7,502)
Total Assets 2,541 3,925 7,442 10,671
Total Debt 9,124 6,296 1,956 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AgeX Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AgeX Therapeutics‘s full profile, request access.

Request a free trial

AgeX Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Michael West Ph.D Chief Executive Officer & Board Member
Andrea Park Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Ivan Labat Ph.D Chief Information Officer
Hal Sternberg Ph.D Vice President
Dana Larocca Ph.D Vice President, Discovery Research
You’re viewing 5 of 7 executive team members. Get the full list »

AgeX Therapeutics Board Members (6)

Name Representing Role Since
Annalisa Jenkins Self Board Member 000 0000
Gregory Bailey MD Self Chairman & Board Member 000 0000
Michael West Ph.D AgeX Therapeutics Chief Executive Officer & Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

AgeX Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AgeX Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 16-Aug-2019 000000000 00000 00 Buildings and Property 0000000 0000 00.0
To view AgeX Therapeutics’s complete investments history, request access »